^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

MB-CART 19.1

i
Associations
Company:
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Miltenyi Biotec
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations